RMS MEDICAL PRODUCTS ANNOUNCES REBRANDING TO KORU MEDICAL SYSTEMS NEW TICKER SYMBOL "KRMD" CHESTER, NY

RMS MEDICAL PRODUCTS ANNOUNCES REBRANDING TO KORU MEDICAL SYSTEMS

NEW TICKER SYMBOL "KRMD"

CHESTER, NY - October 23, 2019

- Repro Med Systems, Inc. (NASDAQ: REPR) ("the Company") today announced a new dba name, KORU Medical

Systems, which the Company will begin using in place of RMS Medical Products on October 24, 2019. Reflecting this change,

the Company's common stock will commence trading under the new ticker symbol "KRMD" on the NASDAQ effective

The Company announced the

rebranding on the eve of this year's Immunoglobulin National Society Conference (IgNS 2019) in Las Vegas, Nevada, a

unique, multi-disciplinary gathering of nurses, pharmacists, physicians, and Ig industry leaders. The Company's management

team and board of directors will be attending IgNS 2019.

"Our decision to rebrand the Company reflects the great strides we have made in evolving our corporate

culture, mission, and philosophy to a more patient-centric focus," said Don Pettigrew, President and CEO.

"The rebranding is inspired by the

koru, a widely recognized symbol of a spiral-shaped, unfurling fern that represents new life and new beginnings," said

Mr. Pettigrew. "KORU Medical Systems' focus on providing patients' new beginnings with our at-home infusion

systems is at the heart of our brand."

On October 24, 2019 the Company's

email address will change to the domain @korumedical.com and its home page will become www.korumedical.com.

The Committee on Uniform Securities

Identification Procedures (CUSIP) number assigned to the Company's common stock will remain the same. The dba name

change will not affect the rights of the Company's stockholders. The Company's corporate name, Repro Med Systems, Inc.,

will not change as a result of the dba name change at this time.

The Company develops, manufactures and

commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the

world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60 and FreedomEdge

Syringe Infusion Drivers, Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle

Sets . These devices are used for infusions administered in the home and alternate care settings.

Forward-Looking Statements

The statements contained herein include

prospects, statements of future expectations and other forward-looking statements within the meaning of the Private

Securities Litigation Reform Act of 1995 that are based on management's current views and assumptions and involve known and

unknown risks and uncertainties, identified by words such as "will." Actual results, performance or events may

differ materially from those expressed or implied in such forward-looking statements. Factors that may cause actual results

to differ materially from current expectations and other risks are discussed in the Company's filings with the U.S.

Securities and Exchange Commission, including its Annual Report on Form 10-K, which filings are available from the SEC and

the Company's website. The Company undertakes no obligation to update any forward-looking statements.